Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTINA L SHENVI

Allopathic & Osteopathic Physicians Emergency Medicine

NPI
1356668495
CMS profile
1294882
Location
CHAPEL HILL, NC

General Payments · PY2023–2024

$10,982.07

  • Reported across 13 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$9,764.20

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $6,701.70 8
Noven Pharmaceuticals, Inc. $3,062.50 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $1,217.87 2
PY2024 $9,764.20 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $100.00 05/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105402822 CMS
AstraZeneca Pharmaceuticals LP $300.00 05/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104405237 CMS
AstraZeneca Pharmaceuticals LP $89.51 08/15/2024 Travel and Lodging Undisputed 01/23/2026 1104208303 CMS
AstraZeneca Pharmaceuticals LP $107.95 08/15/2024 Food and Beverage Undisputed 01/23/2026 1104510406 CMS
AstraZeneca Pharmaceuticals LP $2,950.00 08/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105574870 CMS
AstraZeneca Pharmaceuticals LP $82.41 09/25/2024 Travel and Lodging Undisputed 01/23/2026 1104211987 CMS
AstraZeneca Pharmaceuticals LP $121.83 09/25/2024 Food and Beverage Undisputed 01/23/2026 1104236517 CMS
AstraZeneca Pharmaceuticals LP $2,950.00 10/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104597524 CMS
Noven Pharmaceuticals, Inc. $1,750.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1084816644 CMS
Noven Pharmaceuticals, Inc. $787.50 11/15/2024 Consulting Fee Undisputed 01/23/2026 1084816648 CMS
Noven Pharmaceuticals, Inc. $525.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1084816646 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.